Free Trial

Vicarious Surgical (RBOT) Competitors

Vicarious Surgical logo
$9.15 +0.12 (+1.33%)
(As of 09:48 AM ET)

RBOT vs. ZJYL, LAKE, SPAI, APT, MLSS, NTRB, CLGN, COCH, LFWD, and POAI

Should you be buying Vicarious Surgical stock or one of its competitors? The main competitors of Vicarious Surgical include Jin Medical International (ZJYL), Lakeland Industries (LAKE), Safe Pro Group Inc. Common Stock (SPAI), Alpha Pro Tech (APT), Milestone Scientific (MLSS), Nutriband (NTRB), CollPlant Biotechnologies (CLGN), Envoy Medical (COCH), ReWalk Robotics (LFWD), and Predictive Oncology (POAI). These companies are all part of the "surgical appliances & supplies" industry.

Vicarious Surgical vs.

Jin Medical International (NASDAQ:ZJYL) and Vicarious Surgical (NYSE:RBOT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their community ranking, risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

Vicarious Surgical received 8 more outperform votes than Jin Medical International when rated by MarketBeat users.

CompanyUnderperformOutperform
Jin Medical InternationalN/AN/A
Vicarious SurgicalOutperform Votes
8
33.33%
Underperform Votes
16
66.67%

Jin Medical International has higher revenue and earnings than Vicarious Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jin Medical International$19.82M8.05$2.88MN/AN/A
Vicarious SurgicalN/AN/A-$71.07M-$10.29-0.89

Jin Medical International has a beta of 16.25, suggesting that its stock price is 1,525% more volatile than the S&P 500. Comparatively, Vicarious Surgical has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500.

In the previous week, Jin Medical International's average media sentiment score of 1.86 beat Vicarious Surgical's score of -0.80 indicating that Jin Medical International is being referred to more favorably in the media.

Company Overall Sentiment
Jin Medical International Very Positive
Vicarious Surgical Negative

Vicarious Surgical has a consensus price target of $10.25, indicating a potential upside of 12.02%. Given Vicarious Surgical's stronger consensus rating and higher possible upside, analysts plainly believe Vicarious Surgical is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jin Medical International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Vicarious Surgical
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

47.3% of Vicarious Surgical shares are owned by institutional investors. 11.7% of Vicarious Surgical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Jin Medical International's return on equity of 0.00% beat Vicarious Surgical's return on equity.

Company Net Margins Return on Equity Return on Assets
Jin Medical InternationalN/A N/A N/A
Vicarious Surgical N/A -81.46%-63.62%

Summary

Jin Medical International beats Vicarious Surgical on 6 of the 11 factors compared between the two stocks.

Get Vicarious Surgical News Delivered to You Automatically

Sign up to receive the latest news and ratings for RBOT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RBOT vs. The Competition

MetricVicarious SurgicalSurgical appliances & supplies IndustryMedical SectorNYSE Exchange
Market Cap$53.99M$9.70B$5.07B$19.90B
Dividend YieldN/A1.10%4.99%3.49%
P/E Ratio-0.8915.9889.5636.63
Price / SalesN/A30.301,224.8017.98
Price / CashN/A23.2339.4521.28
Price / Book0.934.826.974.58
Net Income-$71.07M$182.72M$119.04M$985.06M
7 Day Performance-13.02%2.76%-1.78%0.51%
1 Month Performance11.18%-3.62%-3.59%1.13%
1 Year Performance-15.51%-2.10%31.64%24.80%

Vicarious Surgical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RBOT
Vicarious Surgical
2.0623 of 5 stars
$9.15
+1.3%
$10.25
+12.0%
-26.1%$53.99MN/A-0.893
ZJYL
Jin Medical International
N/A$1.03
+2.0%
N/A-94.1%$159.65M$19.82M0.00245Positive News
Gap Down
LAKE
Lakeland Industries
4.4003 of 5 stars
$21.50
+1.7%
$26.50
+23.3%
+44.7%$159.10M$124.69M88.081,750News Coverage
SPAI
Safe Pro Group Inc. Common Stock
N/A$5.04
+57.5%
N/AN/A$69.35MN/A0.0011News Coverage
Gap Up
High Trading Volume
APT
Alpha Pro Tech
N/A$5.21
-0.6%
N/A+11.1%$57.31M$61.23M14.46120
MLSS
Milestone Scientific
2.1757 of 5 stars
$0.70
+2.5%
$1.25
+79.8%
-15.8%$54.15M$9.83M0.0030Analyst Forecast
NTRB
Nutriband
0.6307 of 5 stars
$4.86
-2.4%
N/A+125.3%$54.00M$2.09M0.0010
CLGN
CollPlant Biotechnologies
1.8582 of 5 stars
$4.23
+1.0%
$11.00
+160.0%
-24.2%$48.43M$10.96M0.0070Upcoming Earnings
COCH
Envoy Medical
3.0747 of 5 stars
$2.06
-4.2%
$7.92
+284.3%
+115.0%$40.38M$320,000.000.0034Gap Up
LFWD
ReWalk Robotics
3.5648 of 5 stars
$1.86
+0.5%
$13.00
+598.9%
N/A$16.39M$13.85M-0.7460Gap Down
POAI
Predictive Oncology
2.1484 of 5 stars
$0.64
-2.4%
$3.00
+371.2%
-78.2%$4.25M$1.78M0.0030Analyst Revision

Related Companies and Tools


This page (NYSE:RBOT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners